Tien Liang BioTech Co., Ltd. (4127.TWO)

TWD 40.9

(0.25%)

Long Term Debt Summary of Tien Liang BioTech Co., Ltd.

  • Tien Liang BioTech Co., Ltd.'s latest annual long term debt in 2023 was 377 Thousand TWD , down -57.01% from previous year.
  • Tien Liang BioTech Co., Ltd.'s latest quarterly long term debt in 2024 Q2 was 33.72 Million TWD , down 0.0% from previous quarter.
  • Tien Liang BioTech Co., Ltd. reported annual long term debt of 877 Thousand TWD in 2022, down -37.22% from previous year.
  • Tien Liang BioTech Co., Ltd. reported annual long term debt of 1.39 Million TWD in 2021, down -35.74% from previous year.
  • Tien Liang BioTech Co., Ltd. reported quarterly long term debt of 33.72 Million TWD for 2024 Q2, down 0.0% from previous quarter.
  • Tien Liang BioTech Co., Ltd. reported quarterly long term debt of 628 Thousand TWD for 2023 Q2, down -16.49% from previous quarter.

Annual Long Term Debt Chart of Tien Liang BioTech Co., Ltd. (2023 - 2019)

Historical Annual Long Term Debt of Tien Liang BioTech Co., Ltd. (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 377 Thousand TWD -57.01%
2022 877 Thousand TWD -37.22%
2021 1.39 Million TWD -35.74%
2020 2.17 Million TWD 0.0%
2019 - TWD 0.0%

Peer Long Term Debt Comparison of Tien Liang BioTech Co., Ltd.

Name Long Term Debt Long Term Debt Difference
Allied Biotech Corporation 72.02 Million TWD 99.477%
GeneFerm Biotechnology Co., Ltd. 76.14 Million TWD 99.505%
Easywell Biomedicals, Inc. 330.44 Million TWD 99.886%
TTY Biopharm Company Limited 403.04 Million TWD 99.906%
Synmosa Biopharma Corporation 1.45 Billion TWD 99.974%
Orient EuroPharma Co., Ltd. 2.2 Billion TWD 99.983%
Center Laboratories, Inc. 4.42 Billion TWD 99.991%
Orient Pharma Co., Ltd. 323.73 Million TWD 99.884%
InnoPharmax Inc. 5.38 Million TWD 93.0%
Johnson Chemical Pharmaceutical Works Co., Ltd. 100.83 Million TWD 99.626%
Excelsior Biopharma Inc. 300.25 Million TWD 99.874%
DV Biomed Co., Ltd. 315.74 Million TWD 99.881%
Foresee Pharmaceuticals Co., Ltd. 13.11 Million TWD 97.125%
Handa Pharmaceuticals, Inc. 7.67 Million TWD 95.085%
UniPharma Co., Ltd. - TWD -Infinity%
Anxo Pharmaceutical Co., Ltd. 499.69 Million TWD 99.925%
Alar Pharmaceuticals Inc. 138 Thousand TWD -173.188%
Winston Medical Supply Co., Ltd. 56.05 Million TWD 99.327%
Mercury Biopharmaceutical Corporation 41.66 Million TWD 99.095%
Bioray Biotech Co., Ltd 65.65 Million TWD 99.426%
TSH Biopharm Corporation Limited - TWD -Infinity%